Comparison of Delta and Omicron variant of COVID-19 infection cases in Montenegro

Author:

Grbovic Ena1,Galic Igor1,Grbovic Mensud2,Madzgalj Jasmina3

Affiliation:

1. Institute of Public Health of Montenegro, Podgorica, Montenegro

2. Vaše zdravlje Private Health Care Institution, Podgorica, Montenegro

3. Secretariat for Environmental Protection, Belgrade, Serbia

Abstract

Introduction/Objective. At the end of 2021, Omicron wave (B.1.1.529) SARS-CoV-2 variant superseded the Delta variant (B.1.617). The main goal of the research is to provide a detailed and comprehensive presentation of data related to people infected with the coronavirus in Montenegro. The specific goal of the research is to determine whether virus mutations influenced the course of the epidemic during its two-year duration. Methods. This is a retrospective study. We used data from the Institute of Public Health of Montenegro. Our sample consisted of 127,134 people who tested positive for Delta or Omicron infection aged 0?100 years, who had a positive PCR test for COVID-19 between August 17, 2021 and April 17, 2022. Results. The respondents aged 40?49 years were taken as a reference group for age. The results showed that the age group from 20 to 29 years old was affected 1.03 times more than the reference group ? persons belonging to the age group of 30?39 years were affected 1.07 times more than the reference group. The Central region was taken as the reference group for the region. The results showed that people who live in southern region got sick 1.14 times more often and people who live in northern region got sick 1.20 times less than people from the central region. Conclusion. The biggest predictor that a person would get sick is the age group. Also, the predictor is the region, and in our research, it was southern region.

Publisher

National Library of Serbia

Subject

General Medicine

Reference11 articles.

1. Mahase E. Delta variant: What is happening with transmission, hospital admissions, and restrictions? BMJ. 2021;373:n1513. [DOI: 10.1136/bmj.n1513] [PMID: 34130949]

2. Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021;20(10):1201-9. [DOI: 10.1080/14760584.2021.1976153] [PMID: 34488546]

3. Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J Med Virol. 2022;94(4):1641-9. [DOI: 10.1002/jmv.27526] [PMID: 34914115]

4. World Health Organization. Weekly epidemiological update on COVID-19 - 28 December 2021; 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-oncovid-19---28-december-2021

5. Hu T, Zhang M, Deng A, Zhang Y, Li B, Li Y, et al. Comparison of Omicron and Delta Variant Infection COVID-19 Cases - Guangdong Province, China, 2022. China CDC Wkly. 2022;4(18):385-8. [DOI: 10.46234/ccdcw2022.087] [PMID: 35686204]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3